Link Roundup!

For this week’s link roundup, we’ll first share a couple other perspectives on Judge Albright’s most recent updates to his Order Governing Proceedings (v3.2):

Let’s also look at some other takes on the Federal Circuit’s In re Apple mandamus order, of varying rhetorical spiciness:

And finally, some other IP-related links for your weekend-reading pleasure:

  • After several successfully-completed trials during the time of COVID-19, there was finally one where the coronavirus disrupted proceedings: EDTX Trial Suspended After Juror, Attorney Get COVID-19 (Law360; subscription requirement waived for pandemic-related coverage)
  • Akkad Y. Moussa of Kilpatrick Townsend examines the PTAB’s Legal Experience and Advancement Program (LEAP), designed to provide incentives for parties to allow more junior attorneys opportunities for oral argument: Reflections on the USPTO’s LEAP
  • And in news of a type of patent litigation not often (or ever?) seen in the Waco Division, Perry Cooper of Bloomberg Law addresses the Federal Circuit’s recent Valeant v. Mylan decision, clarifying that a patent suit under the Hatch-Waxman Act relating to a generic pharmaceutical company’s filing of an Abbreviated New Drug Application can be filed “only in districts where actions related to the ANDA submission occur”: Drug Patent Owners Face New Venue Hurdle in Anti-Generic Cases

Disclaimer: We share these links because we think they’re worth reading. Our doing so does not necessarily imply that we endorse any of the viewpoints expressed by the authors (unless we’re the authors).